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Abstract
Bulbar motor deterioration due to amyotrophic lateral sclerosis (ALS) leads to the eventual impairment of speech and
swallowing functions. Despite these devastating consequences, no standardized diagnostic procedure for assessing bulbar
dysfunction in ALS exists and adequate objective markers of bulbar deterioration have not been identified. In this paper,
we consider objective measures of speech motor function, which show promise for forming the basis of a comprehensive,
quantitative bulbar motor assessment in ALS. These measures are based on the assessment of four speech subsystems:
respiratory, phonatory, articulatory, and resonatory. The goal of this research is to design a non-invasive, comprehensive
bulbar motor assessment instrument intended for early detection, monitoring of disease progression, and clinical trial
application. Preliminary data from an ongoing study of bulbar motor decline are presented, which demonstrate the potential
clinical efficacy of the speech subsystem approach.
Key words: Bulbar motor, amyotrophic lateral sclerosis, oral motor, speech assessment, speech intelligibility, speaking rate,
speech movement analysis

Bulbar motor assessment in ALS: Challenges
and future directions
Progressive bulbar motor deterioration as a result of
amyotrophic lateral sclerosis (ALS) leads to the
eventual impairment of speech and swallowing function. At time of diagnosis, up to 30% of patients with
ALS present with bulbar symptoms (1). Regardless
of the site of onset, most patients with ALS will experience bulbar symptoms, which significantly impact
the quality of life and shorten survival (2,3). Despite
these devastating consequences, no standardized
diagnostic procedure for assessing bulbar dysfunction in ALS exists, and adequate objective markers
of bulbar deterioration have yet to be identified.
Consequently, little is known about the natural history of bulbar deterioration, and clinicians invariably
find it challenging to predict the rate of speech and
swallowing decline. Objective bulbar assessment

strategies are needed for improving early disease
detection, monitoring disease progression, and optimizing the efficacy of therapeutic ALS drug trials.
Improved prediction accuracy of bulbar decline is
also critical for clinical care because decisions regarding communication intervention and palliative care
are most effective when made prior to the loss of
speech intelligibility (4).
A significant obstacle, however, has been the
logistical difficulties posed by the inaccessibility
and complexity of the bulbar apparatus. Although
advanced instrumentation-based methods of bulbar
assessment exist (5), most are designed for the
assessment of speech production and remain unfamiliar to neurologists or other members of the
ALS clinical team. Moreover, their reliability, validity, and responsiveness to bulbar motor deterioration
are not well established.
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Bulbar and speech motor assessment
Neurologic examination and basic speech testing have been components of the standard bulbar
assessment battery for decades, yet these assessments appear to be insensitive to the early phases
of bulbar deterioration. Numerous studies have
demonstrated, for example, that bulbar motor dysfunction occurs prior to perceived changes in speech
intelligibility (4,6–11). Speaking rate, as measured
in words per minute (wpm), has been observed to
decline prior to speech intelligibility. As this rate
drops below 100–120 wpm, speech intelligibility
tends to decline rapidly (4,10). The diagnostic value
of this measure for detecting disease onset, however, is questionable because even healthy individuals vary considerably in their habitual speaking
rates (12) and are capable of using various strategies (11) for maintaining this rate as oromotor
strength declines (8).
Over the past several decades, a relatively small
number of speech researchers have worked to
develop selective measures of speech subsystem
motor involvement (see (5)). These speech subsystem measures are more sensitive than current best
practices for detecting subclinical changes in bulbar
motor performance. The extant work on these measures has, however, largely focused on the testing
of a single speech subsystem (e.g. phonatory, articulatory, or resonatory) in populations with motor
disorders other than ALS. The intent of this review
is to integrate this disparate literature by 1) identifying promising instrumental measures of speech
subsystem performance; and 2) presenting preliminary findings demonstrating the diagnostic potential of these measures relative to those currently
used in translational research and clinical practice.
The ultimate purpose of this research is to design
a minimally invasive yet comprehensive bulbar
motor assessment instrument that is readily adaptable to clinical settings, and intended for the monitoring of disease progression and clinical trial
application.

Framework for the assessment of bulbar impairment:
a speech subsystem approach
Speech researchers traditionally include the bulbar
system as part of the larger speech production network, comprised of four distinct subsystems (13–15):
respiratory, phonatory, articulatory, and resonatory
(see Figure 1). In this review, we highlight several
instrumental based measures that when combined,
show promise for forming the basis of a comprehensive, quantitative bulbar motor assessment in ALS.
In addition, preliminary data are presented that
demonstrate the feasibility of this approach. The
applied goal of this instrument is to improve early
detection of bulbar involvement and to provide a
reproducible, quantitative index of change in the rate
of bulbar progression.
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Figure 1. The four speech subsystems.

The respiratory subsystem. ALS inevitably results in
weakening of the respiratory musculature characterized by symptoms of dyspnea on exertion, orthopnea, and early morning headaches with fatigue.
Respiratory failure remains the leading cause of
death (16). The average rate of decline in vital capacity is reported to be 1.8% per month in patients with
slowly progressive ALS and 3.5% per month in rapidly progressive disease (17,18). Although respiratory function is accurately documented through
spirometry (19), the measured effects on speech
communication remain poorly understood. Speech
breathing patterns are quantified using technologies
that record chest wall movements, oral pressures and
flows, and speech acoustics. The most extensively
studied aspect of speech breathing decline in persons
with ALS has been the patterns of pauses in acoustic
recordings of connected speech (9,20). Because
respiratory muscle weakness necessitates more frequent inspirations during speech, persons with ALS
exhibit longer and more frequent pauses than do
healthy controls (20).
The phonatory subsystem. Perceptible changes in
voice quality or loudness may be the fi rst symptom
of bulbar involvement, even in spinal-onset disease
(21,22). The consistent pattern of vocal fold
vibration is a function of muscular tension, the viscoelastic properties of vocal fold tissue, and the air
pressure and flow generated by the lungs (23).
Because voice quality is affected by multiple factors,
the assessment of the laryngeal subsystem requires
evaluation of multiple voice variables.
Auditory perceptual (i.e. listening-based) judgments of voice characteristics, including roughness,
strain, breathiness, and loudness, are the most common measures of laryngeal involvement assessed
by speech-language pathologists (24). Previous
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studies have suggested more than 60% of all patients
with ALS exhibit changes to vocal quality such as
tremor, breathiness, and harshness (25). Recordings
of voice acoustics and aerodynamics provide a
more objective assessment of phonatory function
than subjective judgments of voice quality, which
requires special training and can be unreliable (26).
In persons with ALS, phonatory function decline has
been detected prior to speech decline using acoustic
measures of voice (27). Although abnormal phonatory characteristics associated with ALS vary considerably, phonatory dysfunction has been characterized
as abnormal vocal pitch (too high or low), limited
pitch range, instability of vocal fold vibration, and
high noise-to-harmonic ratios (21,22,25,28–31).
The latter measure quantifies the amount of noise in
the voice signal.

due to cleft lip and palate (34,35). Delorey et al. (32)
reported significant changes across a six-month
interval in nasalance for groups of participants with
bulbar and spinal deterioration due to ALS. The
measure was able to differentiate the bulbar group
from the spinal group and healthy controls at both
recordings, with the bulbar group exhibiting greater
nasalance scores than the other groups.
The articulatory subsystem. Testing of articulatory
involvement is achieved through measures of oral
movement and strength. Speech is the product of
highly coordinated movements of the tongue, lips,
and jaw. The small movements of the lips and jaw
can be non-invasively recorded using computerbased optical tracking systems (36). Magnetic
(37,38) or imaging technologies such as dynamic
MRI (39) and ultrasound (40) are currently
required to capture the movements of the tongue
inside the mouth. Multiple features of motor performance can be evaluated from speech movement
recordings including movement extent, speed, and
acceleration (see (41)). Other variables often
measured include the regularity of the movement
patterns (42,43) and the temporal coordination
between the movements of different articulators
(36).
As ALS progresses, speech movements become
smaller in extent, slower in speed and longer in
duration (8,44–47). In some individuals, the longitudinal course of decline is interrupted by a transient
increase in movement extent and speed, particularly
in the jaw (47,48). These studies also reported
that the speed of speech movements was more consistently affected in ALS than several other measurable speech variables. Movement speed may be a
particularly sensitive index of early motor deterioration in ALS as the disease appears to selectively
affect fast-twitch muscles, as noted in early phases
of the motor neuron disease mouse model when the
animal is presymptomatic (49,50).
The force generating capacities of the jaw, lips
and tongue can be measured using either a strain
gauge (51) or pneumatic pressure bulb (52). Static
measures are intended to test force generating
capacity (strength and endurance) and dynamic

The resonatory subsystem. Velopharyngeal muscle
weakness leads to continual opening of the velopharyngeal port during speech. Acoustic energy then
enters the nasal cavity producing abnormal nasal
resonances. Consequently, speech becomes excessively nasal (or hypernasal) with speech sounds
becoming less distinct and weak in intensity. In
severe cases of velopharyngeal incompetence,
speech can be rendered unintelligible. Although
velopharygeal function has rarely been investigated
in ALS (e.g. (32)), the existing data suggest
that hypernasality may be a defi ning characteristic
of bulbar disease. Carrow et al. (25) reported
that 75% of the 79 patients they studied with motor
neuron disease exhibited hypernasality.
Due to its inaccessibility, velopharygeal functioning is rarely studied directly. Aerodynamic or acoustic methods are traditionally used to detect spurious
nasal airflow emissions or the presence of nasal resonances (see (33)). Nasalance, the relative proportion of nasal to oral acoustic energy in speech, is
widely used by speech-language pathologists to
assess velopharyngeal function. Nasalance scores
correlate well with listeners’ perceptions of nasality
due to ALS (32). The measure has been shown to
be reliable (test-retest error ⫽ 2%), and has a high
specificity (87%–93%) and a high sensitivity (83%–
97%) in persons with velopharyngeal incompetence

Table I. Participant characteristics for the Control, ALS Normal Speech, and ALS Impaired Speech groups. The values for
Gender and Onset are counts, and the values for all other variables are means (standard deviations). FVC refers to predicted forced
vital capacity.
Gender
Group
Healthy
controls
ALS Normal
Speech
ALS Impaired
Speech

Male Female

Age (years)

Months
since onset
–

4

6

60.10 (10.54)

6

4

5

5

Onset
bulbar spinal

ALSFRS-R ALSFRS-R
Total
Bulbar
–

Speech
Intell

–

–

55.69 (11.20) 57.30 (50.74)

2∗

9∗

33.00 (5.40) 10.00 (1.70) 2.67 (1.14) 99.73 (0.61)

59.41 (11.79) 33.30 (21.35)

4

6

33.00 (9.29)

∗Onset for one subject was both bulbar and spinal.

–

FVC

3.00 (1.36) 98.71 (1.23)

8.60 (1.71) 2.53 (1.13) 91.45 (3.64)

Bulbar and speech motor assessment
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Table II. Instrumentation-based speech subsystem variables recorded in this study.
Speech subsystem
Respiratory
Phonatory
Resonatory
Articulatory
Jaw
Lip
Tongue

Measure

Experimental tasks

Percent pause (%)
Noise to harmonic ratio
Nasalance (%)

Reading of Bamboo passage
Sustained “ah”
Sentence repetition: “Buy Bobby a puppy ”

Peak movement speed (mm/s)
Peak movement speed (mm/s)
Peak movement speed (mm/s)

Word repetition: “uhpah”
Word repetition: “uhpah”
Word repetition: “I owe you a yoyo today ”

measures are intended to assess force regulation
(motor control). The maximum force and peak
rate of change of force in the tongue and lips are
markedly reduced in ALS (6,53). The test-retest reliability of oral strength measures varies across studies
from moderate (54) to high (55). Common to all
maximum performance assessments, oral strength
scores are affected by age, gender, practice and motivation (56). These factors may drive the large population variance reported with these measures, limiting
their usefulness in clinical trials (57).
Towards an objective bulbar assessment:
preliminary data
Below we present preliminary data from an
ongoing study of bulbar motor decline, demonstrating the use of subsystem measures for the assessment of bulbar disease onset and progression. The
analyses were based on cross-sectional data from 30
participants: 10 healthy controls and 20 participants
with ALS. The participants with ALS were stratified
into two groups (10 participants per group) based
on their speech intelligibility scores: ALS Normal

Speech (100–97%) and ALS Impaired Speech
(96–86%). Information about the characteristics of
each participant group is provided in Table I.
The respiratory, phonatory and resonatory subsystems were evaluated using the methods described
above and previously in Yunusova et al. (5). The
assessors were blinded to group assignment and
ALS diagnosis. Table II shows the speech subsystem
variables that were collected in addition to speech
intelligibility (%), speaking rate (words per minute),
and a bulbar severity score, which was derived
by summing the scores from the three questions
about speech, swallowing, and salivation on
the Amyotrophic Lateral Sclerosis Functional Rating
Scale-Revised (58–60). The mean values for each
group and variable are displayed in Figure 2. All
group differences were tested using t-tests for independent samples using an alpha level of .05.

Early detection of bulbar involvement. As displayed in
Figure 2, statistically significant differences were
observed for speaking rate, lower lip, jaw, and
tongue. The between-group effect sizes for these

Figure 2. The mean values and standard error for each group and variable. Statistically significant comparisons are marked with
horizontal brackets.
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Figure 3. Effect sizes for each speech variable representing the differences between the healthy controls and the ALS participants
with normal speech intelligibly. Statistically significant comparisons are marked with asterisks.

data are presented in Figure 3. For each speech
system and subsystem measure, we computed the
Cohen’s d effect sizes (expressed in absolute value)
between healthy controls and persons in the ALS
Normal Speech group. Based on Cohen’s conventions (61), the observed effect sizes were large for
the tongue, medium for lower lip and jaw, and small
for speaking rate. The observation of early tongue
signs is consistent with prior reports from studies
of muscle strength and articulatory movements
(6,40,42,62).
Changes during the mild to moderate phase of speech
impairment. As displayed in Figure 2, statistically
significant differences were observed for speaking
rate, ALSFRS-R bulbar subscore, lower lip, and
tongue. It is notable that the lower lip movement
speed was faster for the ALS Impaired Speech

group than for the ALS Normal Speech Group and
that jaw movement speed showed a similar trend.
This unexpected increase in lip and jaw movement
speed with disease progression is thought to be a
compensatory response to the slowing of tongue
movements (47,48).
For each speech system and subsystem measure,
the Cohen’s d effect sizes (expressed in absolute
value) between the ALS Normal Speech group
and the ALS Impaired Speech group were also
computed (Figure 4). Effect sizes were large for the
lower lip and tongue speeds, and marginally large
for speaking rate.
Conclusions
The reliable assessment of bulbar involvement in
ALS continues to be a significant clinical and research
challenge.

Figure 4. Effect sizes for each speech variable representing the differences between participants with ALS who had normal
speech and who had impaired speech. Statistically significant comparisons are marked with asterisks.

Bulbar and speech motor assessment
Overall, our preliminary findings suggest that
measures of speech motor performance, in particular
tongue movement speed, may be well suited for both
early detection and progress monitoring. Speaking
rate was also an effective measure for both early
detection and progress monitoring, but was only
associated with mild to moderate effect sizes. The
ALSFRS-R bulbar subscore and several of the speech
subsystem measures did not detect differences
among the groups in this sample.
Longitudinal studies with a larger pool of participants are required to further interrogate the
clinical efficacy of different bulbar measures,
which should include determining each measure’s
psychometric properties (e.g. reliability, validity,
specificity, sensitivity). Additional work also is needed
to address barriers to clinical implementation including high equipment cost, equipment complexity,
and the burden of data reduction. These issues are
being actively investigated by multidisciplinary
research teams focused on developing improved
speech movement tracking hardware and intelligent
algorithms to identify abnormal speech and voice
patterns in large datasets (64).
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